{"id":24692,"date":"2020-01-09T10:17:00","date_gmt":"2020-01-09T10:17:00","guid":{"rendered":"https:\/\/www.neurodegenerationresearch.eu\/?p=24692"},"modified":"2020-01-20T08:59:25","modified_gmt":"2020-01-20T08:59:25","slug":"jpnd-launches-a-new-call-on-novel-imaging-and-brain-stimulation-methods-and-technologies-related-to-neurodegenerative-diseases","status":"publish","type":"post","link":"https:\/\/neurodegenerationresearch.eu\/sk\/2020\/01\/jpnd-launches-a-new-call-on-novel-imaging-and-brain-stimulation-methods-and-technologies-related-to-neurodegenerative-diseases\/","title":{"rendered":"JPND LAUNCHES A NEW CALL ON NOVEL IMAGING AND BRAIN STIMULATION METHODS AND TECHNOLOGIES RELATED TO NEURODEGENERATIVE DISEASES"},"content":{"rendered":"
[vc_row][vc_column width=“1\/1″][vc_column_text]\n

A CALL FOR NOVEL IMAGING AND BRIAN STIMULATION METHODS AND TECHNOLOGIES RELATED TO NEURODEGENERATIVE DISEASES <\/strong><\/p>\n

The EU Joint Programme \u2013 Neurodegenerative Disease Research (JPND) initiative has announced an \u20ac18 million transnational call for multinational research on novel imaging and brain stimulation methods and technologies for neurodegenerative diseases.<\/i><\/p>\n

With neurodegenerative diseases on the rise and strongly linked to age, as many as 47 millon people worldwide are estimated to be suffering from Alzheimer\u2019s and related disorders today. This figure is expected to double every 20 years as the population ages.<\/p>\n

In recent years, major increases in the range and power of technologies across the basic, clinical and patient-centred domains of JPND have been seen. These include the use of imaging and analysis technologies, from Magnetic Resonance Imaging (MRI) to Position Emission Tomography (PET) to Molecular Imaging at both a molecular and a whole body imaging level, and the use of brain stimulation techniques such as Deep Brain Stimulation (DBS), Neuromodulation and Transcranial Magnetic Stimulation (TMS). Whilst techniques as such help to better understand, treat or diagnose neurodegenerative diseases, there is nevertheless a need to assess the potential of these approaches to deliver new and better treatment options for these debilitating diseases.\u00a0<\/span><\/p>\n

In this context, JPND announced a new call, inviting multinational research teams to submit proposals for ambitious, innovative, multinational and multidisciplinary collaborative research projects\u00a0<\/b>aimed at the development of novel and the advanced use of existing cutting-edge imaging and brain stimulation technologies related to neurodegenerative diseases.<\/p>\n

Professor Philippe Amouyel, University of Lille (France) and Chair of the JPND Management Board<\/b> says: „The incredible progresses of brain imaging and brain stimulation during the last ten years, thanks to the development of new technologies, bioinformatics\u00a0<\/span><\/i>and artificial intelligence, offers new opportunities to better diagnose and alleviate the consequences of neurodegenerative diseases. For its 2020 transnational call, JPND has decided to support ambitious and innovative research projects that will take stock of these new approaches in a trans-disciplinary context. We hope that this highly competitive call will allow us to assess the potential of these approaches to deliver new and better treatment options.\u201d<\/i><\/p>\n

Proposals submitted under this call must focus on one or several of the following neurodegenerative diseases: Alzheimer\u2019s disease and other dementias, Parkinson\u2019s disease and PD-related disorders, Prion diseases, Motor neuron diseases, Spinocerebellar ataxia (SCA), Huntington\u2019s disease, Spinal muscular atrophy (SMA).<\/p>\n

In addition, proposals must focus one or several of the following research areas:<\/p>\n